Hiroyuki Suzuki

15.0k total citations
382 papers, 11.6k citations indexed

About

Hiroyuki Suzuki is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hiroyuki Suzuki has authored 382 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Molecular Biology, 97 papers in Oncology and 64 papers in Immunology. Recurrent topics in Hiroyuki Suzuki's work include Immunotherapy and Immune Responses (41 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Glycosylation and Glycoproteins Research (30 papers). Hiroyuki Suzuki is often cited by papers focused on Immunotherapy and Immune Responses (41 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Glycosylation and Glycoproteins Research (30 papers). Hiroyuki Suzuki collaborates with scholars based in Japan, United States and South Korea. Hiroyuki Suzuki's co-authors include Takumi Noguchi, Norihiro Tokitoh, Renji Okazaki, Tokuo Yamamoto, Satoru Eguchi, Gerald D. Frank, Haruhiko Ohtsu, Miwa Sugiura, Yuichi Ito and Yukinari Kato and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Hiroyuki Suzuki

366 papers receiving 11.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Suzuki Japan 56 5.4k 1.5k 1.3k 1.2k 1.1k 382 11.6k
Brian J. Day United States 64 4.3k 0.8× 772 0.5× 1.2k 1.0× 693 0.6× 786 0.7× 207 11.9k
Masahiko Taniguchi Japan 63 6.1k 1.1× 1.0k 0.7× 1.6k 1.2× 1.4k 1.2× 756 0.7× 504 15.7k
Terry D. Oberley United States 64 6.5k 1.2× 1.3k 0.9× 912 0.7× 646 0.6× 349 0.3× 218 15.0k
Jack R. Lancaster United States 66 4.7k 0.9× 585 0.4× 1.5k 1.1× 622 0.5× 437 0.4× 150 15.1k
Periannan Kuppusamy United States 67 5.6k 1.0× 1.2k 0.8× 1.2k 0.9× 1.1k 0.9× 451 0.4× 378 18.3k
Larry K. Keefer United States 61 3.9k 0.7× 892 0.6× 640 0.5× 1.8k 1.6× 294 0.3× 275 13.9k
Peng Cao China 49 4.4k 0.8× 872 0.6× 468 0.4× 1.3k 1.1× 580 0.5× 401 9.1k
Hiroshi Yamamoto Japan 78 9.2k 1.7× 2.4k 1.6× 3.2k 2.5× 1.6k 1.4× 2.1k 1.9× 710 24.1k
R. Michael Garavito United States 50 6.0k 1.1× 669 0.4× 651 0.5× 1.6k 1.4× 562 0.5× 105 13.0k
William DeGraff United States 45 4.7k 0.9× 1.7k 1.1× 485 0.4× 1.2k 1.0× 553 0.5× 100 10.9k

Countries citing papers authored by Hiroyuki Suzuki

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Suzuki more than expected).

Fields of papers citing papers by Hiroyuki Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Suzuki. The network helps show where Hiroyuki Suzuki may publish in the future.

Co-authorship network of co-authors of Hiroyuki Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Suzuki. A scholar is included among the top collaborators of Hiroyuki Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Suzuki. Hiroyuki Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Hiroyuki, et al.. (2025). Development of an anti-CDH15/M-cadherin monoclonal antibody Ca15Mab-1 for flow cytometry, immunoblotting, and immunohistochemistry. Biochemistry and Biophysics Reports. 43. 102138–102138.
2.
Tanaka, Tomohiro, Yu Kaneko, Hirotaka Yamamoto, et al.. (2025). Development of a novel anti-erythropoietin-producing hepatocellular receptor B6 monoclonal antibody Eb6Mab-3 for flow cytometry. Biochemistry and Biophysics Reports. 41. 101960–101960. 2 indexed citations
3.
Kaneko, Mika K., Hiroyuki Suzuki, Tomokazu Ohishi, et al.. (2025). Antitumor Activities of a Humanized Cancer-Specific Anti-HER2 Monoclonal Antibody, humH2Mab-250 in Human Breast Cancer Xenografts. International Journal of Molecular Sciences. 26(3). 1079–1079. 2 indexed citations
4.
Suzuki, Hiroyuki, Yukihide Watanabe, Mohammed Abdelaziz, et al.. (2025). THG-1/TSC22D4 Promotes IL-1 Signaling through Stabilization of TRAF6 in Squamous Cell Carcinoma. Molecular Cancer Research. 23(5). 463–476.
5.
Arimori, Takao, Emiko Mihara, Hiroyuki Suzuki, et al.. (2024). Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies. Structure. 32(5). 536–549.e5. 11 indexed citations
6.
Okada, Yuki, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K. Kaneko, & Yukinari Kato. (2024). Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 43(2). 44–52. 3 indexed citations
7.
Tanaka, Tomohiro, et al.. (2024). Cx 3 Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 43(3). 90–95. 3 indexed citations
8.
Li, Guanjie, et al.. (2024). Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 43(2). 59–66. 1 indexed citations
9.
Kaneko, Mika K., Hiroyuki Suzuki, & Yukinari Kato. (2024). Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H 2 Mab-250/H 2 CasMab-2 for Breast Cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 43(2). 35–43. 11 indexed citations
10.
Suzuki, Hiroyuki, et al.. (2023). A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences. 24(9). 8411–8411. 7 indexed citations
11.
Suzuki, Hiroyuki, Tomokazu Ohishi, Mika K. Kaneko, & Yukinari Kato. (2023). A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models. Cancers. 15(20). 5080–5080. 5 indexed citations
12.
Suzuki, Hiroyuki, Ling Zheng, Yukari Okita, et al.. (2023). Promotion of squamous cell carcinoma tumorigenesis by oncogene‐mediated THG‐1/TSC22D4 phosphorylation. Cancer Science. 114(10). 3972–3983. 4 indexed citations
13.
Asano, Teizo, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K. Kaneko, & Yukinari Kato. (2022). Identification of the Binding Epitope of an Anti-mouse CCR4 Monoclonal Antibody, C 4 Mab-1. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(4). 214–220. 2 indexed citations
14.
Suzuki, Hiroyuki, et al.. (2022). Development of a Monoclonal Antibody PMab-295 Against Elephant Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41(4). 194–201.
15.
Chen, Chen, Yukari Okita, Yukihide Watanabe, et al.. (2018). Glycoprotein nmb Is Exposed on the Surface of Dormant Breast Cancer Cells and Induces Stem Cell–like Properties. Cancer Research. 78(22). 6424–6435. 42 indexed citations
16.
Okita, Yukari, Chen Chen, Hiroyuki Suzuki, et al.. (2017). The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB. Science Signaling. 10(474). 62 indexed citations
17.
Kaneko, Mika K., Weidong Tian, Shingo Takano, et al.. (2011). Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation. Biochemical and Biophysical Research Communications. 406(4). 608–613. 42 indexed citations
18.
Hashimoto, Kouichi, Hiroyuki Suzuki, Kayoko Taniguchi, et al.. (2008). Catalytic Mechanism of Nitrile Hydratase Proposed by Time-resolved X-ray Crystallography Using a Novel Substrate, tert-Butylisonitrile. Journal of Biological Chemistry. 283(52). 36617–36623. 50 indexed citations
19.
Yuzuriha, Takefumi, Masahiko Okudaira, Itaru Tominaga, et al.. (1997). ALCOHOL-RELATED SUDDEN DEATH WITH HEPATIC FATTY METAMORPHOSIS: A COMPREHENSIVE CLINICOPATHOLOGICAL INQUIRY INTO ITS PATHOGENESIS. Alcohol and Alcoholism. 32(6). 745–752. 12 indexed citations
20.
Tokitoh, Norihiro, et al.. (1994). NEW ASPECTS IN THE CHEMISTRY OF LOW-COORDINATE COMPOUNDS OF GROUP 14 ELEMENTS. Main Group Metal Chemistry. 17(1-4). 55–66. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026